NVOS Annual Cash & Cash Equivalents
$416.30 K
-$1.76 M-80.89%
31 August 2023
Summary:
As of January 28, 2025, NVOS annual cash & cash equivalents is $416.30 thousand, with the most recent change of -$1.76 million (-80.89%) on August 31, 2023. During the last 3 years, it has fallen by -$1.65 million (-79.87%). NVOS annual cash & cash equivalents is now -94.98% below its all-time high of $8.29 million, reached on August 31, 2021.NVOS Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVOS Quarterly Cash And Cash Equivalents
$1.54 M
+$888.10 K+136.27%
31 May 2024
Summary:
As of January 28, 2025, NVOS quarterly cash and cash equivalents is $1.54 million, with the most recent change of +$888.10 thousand (+136.27%) on May 31, 2024. Over the past year, it has increased by +$1.08 million (+231.85%). NVOS quarterly cash and cash equivalents is now -90.34% below its all-time high of $15.94 million, reached on February 28, 2022.NVOS Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVOS Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -80.9% | +231.8% |
| 3 y3 years | -79.9% | +75.2% |
| 5 y5 years | -38.4% | +75.2% |
NVOS Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -95.0% | at low | -90.3% | +269.9% |
| 5 y | 5-year | -95.0% | at low | -90.3% | +269.9% |
| alltime | all time | -95.0% | -90.3% |
Novo Integrated Sciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| May 2024 | - | $1.54 M(+136.3%) |
| Feb 2024 | - | $651.70 K(-60.3%) |
| Nov 2023 | - | $1.64 M(+293.9%) |
| Aug 2023 | $416.30 K(-80.9%) | $416.30 K(-10.3%) |
| May 2023 | - | $464.00 K(-23.9%) |
| Feb 2023 | - | $609.70 K(-30.6%) |
| Nov 2022 | - | $878.70 K(-59.7%) |
| Aug 2022 | $2.18 M(-73.7%) | $2.18 M(-82.8%) |
| May 2022 | - | $12.68 M(-20.5%) |
| Feb 2022 | - | $15.94 M(+81.2%) |
| Nov 2021 | - | $8.80 M(+6.1%) |
| Aug 2021 | $8.29 M(+301.1%) | $8.29 M(-0.9%) |
| May 2021 | - | $8.37 M(+392.6%) |
| Feb 2021 | - | $1.70 M(-13.8%) |
| Nov 2020 | - | $1.97 M(-4.7%) |
| Aug 2020 | $2.07 M(-0.8%) | $2.07 M(+48.3%) |
| May 2020 | - | $1.39 M(+15.3%) |
| Feb 2020 | - | $1.21 M(-37.4%) |
| Nov 2019 | - | $1.93 M(-7.3%) |
| Aug 2019 | $2.08 M(+208.4%) | $2.08 M(-15.9%) |
| May 2019 | - | $2.48 M(+4.4%) |
| Feb 2019 | - | $2.37 M(+155.5%) |
| Nov 2018 | - | $929.10 K(+37.5%) |
| Aug 2018 | $675.70 K(-64.4%) | $675.70 K(-21.8%) |
| May 2018 | - | $863.70 K(-16.7%) |
| Feb 2018 | - | $1.04 M(-20.0%) |
| Nov 2017 | - | $1.30 M(-31.7%) |
| Aug 2017 | $1.90 M(+3386.4%) | $1.90 M(+13.3%) |
| May 2017 | - | $1.67 M(>+9900.0%) |
| Mar 2017 | - | $15.40 K(-71.7%) |
| Dec 2016 | $54.40 K(+285.8%) | $54.40 K(+325.0%) |
| Sept 2016 | - | $12.80 K(-26.9%) |
| June 2016 | - | $17.50 K(-47.8%) |
| Mar 2016 | - | $33.50 K(+137.6%) |
| Dec 2015 | $14.10 K(+683.3%) | $14.10 K(+62.1%) |
| Sept 2015 | - | $8700.00(+4.8%) |
| June 2015 | - | $8300.00(-4.6%) |
| Mar 2015 | - | $8700.00(+383.3%) |
| Dec 2014 | $1800.00 | $1800.00(-68.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2014 | - | $5700.00(>+9900.0%) |
| June 2014 | - | $0.00(-100.0%) |
| Mar 2014 | - | $12.20 K(+258.8%) |
| Dec 2013 | $3400.00(-46.0%) | $3400.00(+580.0%) |
| Sept 2013 | - | $500.00(>+9900.0%) |
| June 2013 | - | $0.00(-100.0%) |
| Mar 2013 | - | $24.50 K(+288.9%) |
| Dec 2012 | $6300.00(-45.7%) | $6300.00(-73.3%) |
| Sept 2012 | - | $23.60 K(+91.9%) |
| June 2012 | - | $12.30 K(+7.0%) |
| Mar 2012 | - | $11.50 K(-0.9%) |
| Dec 2011 | $11.60 K(-91.0%) | $11.60 K(+34.9%) |
| Sept 2011 | - | $8600.00(+19.4%) |
| June 2011 | - | $7200.00(-91.4%) |
| Mar 2011 | - | $84.20 K(-34.4%) |
| Dec 2010 | $128.30 K(-78.7%) | $128.30 K(-63.1%) |
| Sept 2010 | - | $347.50 K(+2.0%) |
| June 2010 | - | $340.70 K(-56.9%) |
| Mar 2010 | - | $791.30 K(+31.1%) |
| Dec 2009 | $603.60 K(>+9900.0%) | $603.60 K(+124.3%) |
| Sept 2009 | - | $269.10 K(+397.4%) |
| June 2009 | - | $54.10 K(-24.8%) |
| Mar 2009 | - | $71.90 K(+2379.3%) |
| Dec 2008 | $2900.00(+3.6%) | $2900.00(-93.8%) |
| Sept 2008 | - | $46.50 K(-4.1%) |
| June 2008 | - | $48.50 K(+3364.3%) |
| Mar 2008 | - | $1400.00(-50.0%) |
| Dec 2007 | $2800.00(+154.5%) | $2800.00(-94.8%) |
| Sept 2007 | - | $53.50 K(+1063.0%) |
| June 2007 | - | $4600.00(-93.1%) |
| Mar 2007 | - | $66.60 K(+5954.5%) |
| Dec 2006 | $1100.00(-91.9%) | $1100.00(-91.7%) |
| Sept 2006 | - | $13.30 K(-48.0%) |
| June 2006 | - | $25.60 K(+1869.2%) |
| Mar 2006 | - | $1300.00(-90.4%) |
| Dec 2005 | $13.50 K(>+9900.0%) | $13.50 K(+4400.0%) |
| Sept 2005 | - | $300.00(-97.6%) |
| June 2005 | - | $12.50 K(+303.2%) |
| Mar 2005 | - | $3100.00 |
| Dec 2004 | $0.00 | - |
FAQ
- What is Novo Integrated Sciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Novo Integrated Sciences?
- What is Novo Integrated Sciences annual cash & cash equivalents year-on-year change?
- What is Novo Integrated Sciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Novo Integrated Sciences?
- What is Novo Integrated Sciences quarterly cash and cash equivalents year-on-year change?
What is Novo Integrated Sciences annual cash & cash equivalents?
The current annual cash & cash equivalents of NVOS is $416.30 K
What is the all time high annual cash & cash equivalents for Novo Integrated Sciences?
Novo Integrated Sciences all-time high annual cash & cash equivalents is $8.29 M
What is Novo Integrated Sciences annual cash & cash equivalents year-on-year change?
Over the past year, NVOS annual cash & cash equivalents has changed by -$1.76 M (-80.89%)
What is Novo Integrated Sciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of NVOS is $1.54 M
What is the all time high quarterly cash and cash equivalents for Novo Integrated Sciences?
Novo Integrated Sciences all-time high quarterly cash and cash equivalents is $15.94 M
What is Novo Integrated Sciences quarterly cash and cash equivalents year-on-year change?
Over the past year, NVOS quarterly cash and cash equivalents has changed by +$1.08 M (+231.85%)